Meet the Authors

Emily Phillips

Principal, Market Access

Part 1: Addressing the Unique Aspects of Rare Disease Product Commercialization

Special Considerations for First-to-Market (VIDEO)

In this video our team shares their experience with best practices for building awareness, educating providers, and overcoming market entry barriers for first-to-market products. It highlights the importance of collaborating with advocacy groups and physician societies to secure diagnosis codes and improve access to rare disease treatments. It emphasizes the need for at least two years of launch planning for rare diseases, focusing on site selection, market education, and genetic testing.

Presenters

Additional Expert Conversation Videos

Rare Disease Product Launch Limited Budget (VIDEO)
This video highlights the challenges of launching an expensive therapy for a rare disease, focusing on partnerships, planning, and tailored care.

Navigating success during a rare disease product launch (VIDEO)
Explore insights on successfully launching products in rare disease markets, with a focus on key success factors and best practices.

Watch the full Fierce Biotech presentation:

Addressing the Unique Aspects of Rare Disease Product Commercialization

Meet the Authors

Emily Phillips

Principal, Market Access

Let's Talk

Herspiegel is a leading professional services firm helping biotech start-ups and the world’s largest pharmaceutical companies navigate the path from science to brand performance and change patients’ lives. We are committed to using strategic insights from medical to commercial to market access to solve critical problems.